Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

WHO ISSUED A LICENSE AND FOR WHAT PURPOSE???

And in November, the Thai government issued a compulsory license for an antiretroviral treatment for HIV without even warning the manufacturer.

Thailand's behavior is hardly unique. Across the world, it has been going on for years. China, for example, produces more patent rip-offs than any other country. And in India, the government recently passed an amendment denying patents to pharmaceuticals derived from "previous knowledge," a purposefully arbitrary phrase.

Meanwhile, Brazil and other Latin American countries have repeatedly threatened to use patent theft to strong-arm pharmaceutical companies.

Even worse, U.S. lawmakers are piling on. Last month, 22 members of Congress signed a letter to the U.S. trade representative expressing their support for the Thai government's renegade action. This is a slap in the face to pharmaceutical companies, whose expensive investments in drug research and technology ensure that these lifesaving medicines exist in the first place.

https://www.baltimoresun.com/news/bs-xpm-2007-02-20-0702200046-story.html

Last week, an Indian company began offering a generic form of the cholesterol-lowering Lipitor in Denmark, despite the fact that the creator of Lipitor still holds the patent. Although the Indian version was already available in India and some other emerging markets, Denmark is the first Western country to sell a copycat version of the drug.